No Data
Daily short sale tracking: Warner Bros Discovery's short volume increased by 4 million, with a short sale ratio of 16%
Marengo Therapeutics Enters Clinical Study Collaboration And Supply Agreement With Gilead Sciences
Express News | Marengo Therapeutics: Under Agreement, Gilead Will Provide Trodelvy to Marengo
Marengo Therapeutics Announces Clinical Study Collaboration With Gilead Sciences to Evaluate Invikafusp Alfa (STAR0602) and Trodelvy in Both Metastatic TNBC and Metastatic HR+/HER2- Breast Cancers
J.P. Morgan Maintains Gilead Sciences(GILD.US) With Buy Rating
Buy Rating Affirmed for Gilead Sciences on Lenacapavir's Market-Changing Potential in PrEP